Chancery Court Awards PharmAthene Damages for Expected Profits
The Delaware Court of Chancery has awarded PharmAthene Inc. lump-sum damages based on the expected profits from a smallpox vaccine it developed with Siga Technologies Inc.
This premium content is reserved for Delaware Business Court Insider subscribers.
Continue reading by getting started with a subscription.
Already a subscriber? Log in now